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ABSTRACT 
MARY NINA WOESSNER: The effects of 28 days of beta-alanine supplementation on the 
physical working capacity at heart rate threshold (PWCHRT). 
(Under the direction of Abbie Smith-Ryan, Ph.D.) 
 
Beta-alanine (BA) supplementation has proven to be an effective means of 
delaying fatigue. The purpose of this study was to determine the effect of 28 days of BA 
supplementation on the physical working capacity at heart rate threshold (PWCHRT), a 
submaximal aerobic fatigue measure. Testing included eight-nine total visits: an 
enrollment day, resting EKG, physical screening, peak oxygen consumption (VO2peak), 
and two PWCHRT assessments over four days. Thirty subjects (mean ± SD; age 21.0 ± 2.1 
years; body mass 72.7 ± 14.5kg; height 170.1 ± 7.9 cm) were randomly assigned to BA 
(n=15) or placebo (PL, n=15) groups. Significant differences existed between BA and PL 
for PWCHRT (p=0.000; BA∆=+24.2, PL∆=+11.2), but not for VO2peak (p=0.222), TTE (p= 
0.562), or VT (p=0.134). Change scores with 95% confidence intervals showed 
significant improvements in PWCHRT and TTE for BA only. BA may increase heart rate 
training threshold. 
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CHAPTER I 
INTRODUCTION 
The ability to delay fatigue may play a crucial role in performance outcomes. The 
point of fatigue onset itself is difficult to pinpoint as there are multiple factors, both 
central and peripheral, that attribute to the body’s inability to produce a maximum force. 
Central fatigue results from the brain reducing neural activation to the working muscles 
during exercise, subsequently causing a decrease in power output,  motivation, and the 
up-regulation of the neurotransmitter serotonin (1).  Peripheral fatigue is defined by 
mechanisms that affect the muscle directly and that are distal to the neuromuscular 
junction (1, 2). While mechanisms of peripheral fatigue include depletion of substrate 
availability, excitation-contraction coupling failure and oxidative stress, during high 
intensity exercise one of the largest contributors to fatigue is metabolite accumulation, 
specifically hydrogen ions (H
+
) (3). During exercise, an increase in metabolism leads to 
excess accumulation of H
+
 by-products from the hydrolysis of ATP (3). An increase [H
+
] 
combined with a corresponding decreasing in intramuscular pH, has been identified as 
one of the primary causes of peripheral fatigue (3). Correspondingly, research has 
demonstrated that delaying the accumulation of H
+
 through buffering mechanisms can 
delay fatigue onset (4-7). 
The human body has natural systems to buffer metabolite accumulation and the 
resulting acidosis. During intense exercise, the lactate and excess H
+
 produced can be 
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monitored by the bicarbonate buffer system by combining the free H
+
 with bicarbonate to 
form a the weaker carbonic acid (8). While this system works to keep the blood pH from 
rising, eventually the H
+
 accumulation overwhelms the system and the pH drops. Another 
endogenous mechanism for buffering the H
+ 
accumulation is muscle carnosine. Muscle 
carnosine acts to maintain acid-base homeostasis by being a H
+
 acceptor (9). Carnosine is 
synthesized in the body naturally by L-histidine and beta-alanine (BA). Research has 
shown that supplementing with BA can significantly increase muscle carnosine levels 
and consequently increase the muscle’s buffering capabilities and delay fatigue onset. (4, 
9-11). 
To pinpoint fatigue onset, various performance tests were developed utilizing fatigue 
variables such as: electromyography (EMG) activity, ventilatory threshold and heart rate 
threshold, to name a few. Originally developed in 1981 by Moritani et al. (12), the 
physical working capacity (PWC) test was designed to determine the point of muscular 
fatigue onset. This category of tests are based on the initial work by Monod and Sherrer 
(13), who developed a relationship between total work done and time to fatigue.  The 
earliest PWC test was based on the physical working capacity at fatigue threshold 
(PWCFT), where the rate of rise in EMG activity as a function of time was calculated at 
four different power outputs. The slopes were plotted against the workloads and the linear 
plot was extrapolated to the point of zero slope which was considered the fatigue 
threshold (12, 14). Studies have previously shown the PWC test to be sensitive to 
changes from training and supplementation (15, 16). Another PWC test utilizing heart 
rate as a fatigue variable may provide additional means for quantifying BA’s buffering 
effect on fatigue. 
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The physical working capacity at heart rate threshold (PWCHRT) test was developed 
by Wagner and Housh (17) to determine the maximum workload an individual can 
maintain on a cycle ergometer without a significant increase in HR. The test involves 
four eight minute cycle rides at different workloads, while measuring the change in HR 
over time. An aerobic training study by Weir et al. (18) demonstrated that the PWCHRT is 
sensitive to adaptations as a result of aerobic training. Another study by Mielke et al. (19) 
aimed to validate the PWCHRT by comparing it to PWCVO2 and ventilatory threshold 
(VT). Findings indicated that the power output at the PWCHRT, PWCVO2 and VT 
thresholds were not significantly different, validating the PWCHRT as an indirect measure 
of fatigue.  
Utilizing HR as a fatigue measure in the current study provides an additional variable 
to quantify fatigue, contributing to the existing body of BA research. A study by Smith et 
al. (20) examined the effects of BA supplementation on women and found that following 
28 days of supplementation, HR and ratings of perceived exertion (RPE) were lower 
during a 40 minute treadmill run compared with placebo subjects. This suggests that BA 
could have a positive effect on HR and RPE during submaximal exercise.  
 Beta-alanine research has shown supplementation has a positive effect on delaying 
fatigue, by way of increasing intramuscular carnosine levels and thereby augmenting H
+ 
buffering (10, 15, 16). Results from a study by Stout et al.(16) indicated that 90 days of 
BA supplementation in an older population can effectively increase the PWCFT. Another 
study by Stout et al. (15) showed that 28 days of BA supplementation in a similar 
population can significantly increase the PWCFT. These studies indicate that physical 
working capacity tests are sensitive enough to assess the effects of BA supplementation, 
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and that BA is effective at increasing fatigue thresholds. No studies to date have assessed 
the effects of BA supplementation on the PWCHRT. 
In addition to previous literature exploring BA’s effect on fatigue thresholds, several 
studies have also examined its influence on aerobic fitness measures such as VO2peak, 
ventilatory threshold (VT) and total time to exhaustion (TTE). Due to BA’s main 
influence being on delaying acidosis, studies have consistently shown it to have no effect 
on VO2peak (a measure than does not mainly rely on anaerobic sources of energy)(10, 11, 
15). Research has given conflicting results for BA’s effect on TTE with some indicating 
BA increasing TTE (10, 21) and some indicating no effect (11). VT has demonstrated 
increases with BA supplementation (10, 21)  indicating that BA has a potential positive 
influence on  aerobic physiological measures that occur at moderate intensities or when 
anaerobic systems begin to play a role (TTE in BA literature is typically taken during 
higher intensity exercises or during VO2peak tests). 
While the focus of BA research involves mechanisms pertaining to peripheral fatigue, 
with the highest levels of carnosine located intramuscularly, there are concentrations 
within the brain and heart tissue as well (22). It is suggested that BA supplementation 
may increase carnosine levels within the brain, thereby affecting the onset of central 
fatigue, as well as peripheral fatigue in the active muscles. It is also well established that 
an increase in H
+
 leads to a decrease in pH which stimulates afferent pain receptors (23). 
The presence of pain could inhibit a person’s willingness and/or motivation to continue 
exercise, thereby initiating volitional fatigue. Therefore, an increase in carnosine can 
delay peripheral as well as central fatigue. While HR accounts for both central and 
 
 
5 
  
 
peripheral factors (24) , it is not the aim of the present study to differentiate between the 
two. 
 
The primary purpose of this study was to determine the effects of 28 days of BA 
supplementation on the PWCHRT. A secondary purpose was to determine if the PWCHRT 
can be used as a predictor for VO2peak. 
 
 
Purpose 
1. The primary purpose of this study was to determine the effect of 28 days of beta-
alanine supplementation, a non-essential amino acid, on the physical working 
capacity at heart rate threshold (PWCHRT). 
2. A secondary purpose was to assess the effect of beta-alanine supplementation on 
aerobic measures- VO2peak, TTE and VT. 
Research Questions 
1. Does four weeks of beta-alanine supplementation increase PWCHRT? 
2. Does four weeks of beta-alanine supplementation increase VO2peak, TTE and VT? 
Hypotheses 
1. PWCHRT will significantly increase following 28 days of beta-alanine 
supplementation. 
2. VO2peak will not significantly increase following 28 days of beta-alanine 
supplementation. 
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3. TTE will significantly increase following 28 days of beta-alanine supplementation 
4. VT will significantly increase following 28 days of beta-alanine supplementation 
 
Delimitations 
1. Thirty-eight recreationally active men and women were recruited to participate in 
this study. 
2. Participants were between the ages of 18-35. 
3. The duration of the study per subject was approximately six weeks including four 
weeks of supplementation. 
4. During a VO2peak oxygen consumption test, VO2peak was measured. 
5. A physical working capacity at heart rate threshold test was completed in order to 
calculate PWCHRT. 
6. Participants had not consumed any performance enhancing supplements 
containing beta-alanine or creatine within the last three months. 
Limitations 
1. Subject recruitment was from exercise classes on campus and through fliers 
located in fitness areas on UNC’s campus. Therefore subject population was not 
truly random. 
2. Due to the time-commitment, participant withdrawal occured. 
Assumptions 
1. Subjects provided accurate health, medical, nutritional and physical activity 
history. 
2. Subjects gave maximal effort during VO2peak testing. 
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3. Subjects adhered to guidelines stipulating no change in normal nutritional and 
exercise patterns. 
4. Subjects complied with the supplementation protocol. 
 
Operational Definitions 
VO2peak – A VO2max is the maximal capacity of an individual’s ability to utilize oxygen 
during exercise and can be used as a measure of physical fitness. It is determined to be 
the point at which oxygen consumption does not increase despite an increase in 
workload. All VO2max tests performed on a cycle ergometer are considered to be peak 
tests (VO2peak). 
 
Physical working capacity at heart rate threshold (PWCHRT)- This assessment is used to 
identify the power output associated with the onset of fatigue, as determined by heart 
rate. Theoretically the PWCHRT represents the highest power output that can be 
maintained for an extended period of time without signs of fatigue, as identified by an 
increase in heart rate. 
 
Recreationally Active – 1-5 hours per week of structured and/or recreational exercise. 
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CHAPTER II 
LITERATURE REVIEW 
Fatigue can be defined as an inability to continually produce maximum force, or 
inability to maintain a given exercise intensity (8). While fatigue can be identified by a 
decrement in force, often the cause of fatigue involve smaller factors that simply lead to a 
disturbance in the body’s ability to maintain homeostasis (8). Fatigue is attributed to 
combined central and peripheral attributes. Central fatigue describes the influence within 
the brain and spinal cord, whereas peripheral fatigue refers to mechanisms that affect the 
muscle directly, distal to the neuromuscular junction (1, 2). Mechanisms of peripheral 
fatigue are numerous and can be traced to excitation-contraction coupling failure, 
depletion of substrate availability, oxidative stress and metabolite accumulation (25). 
During intense exercises,  increases in ATP hydrolysis yields an accumulation  of 
inorganic phosphate (Pi) (3). The hydrolysis of ATP also results in the release of a proton 
in the form of a hydrogen ion (H
+
). While Pi acts as a buffer to the increasing H
+
 
accumulation, the increase in intracellular Pi is much less than the total amount of ATP 
hydrolysis. Due to the hydrolysis of ATP, there is also an accumulation of ADP, which 
combines with Pi to further produce ATP and lactate (3). While other factors of 
metabolite accumulation act on muscular pH and play a role in peripheral fatigue, H
+
 
accumulation is the focus of the current study. An increased [H
+
], and a corresponding 
decrease in pH, is identified as one of the most influential aspects of peripheral fatigue 
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(4). Animal studies have shown a  decrease in pH from 7 to 6 leads to a significant 
decrease in isometric tension in the muscle, resulting in a reduced force production (5). 
Literature has shown that delaying the accumulation of H
+
 may concomitantly delay the 
onset fatigue (4-7). 
Central fatigue is typically defined as a person’s inability to maintain voluntary force 
due to the subconscious brain reducing neural activation to contracting muscles during a 
fatiguing exercise (1, 26). Fatigue in many instances results from an individual’s 
unwillingness to continually produce adequate central drive to maintain a given force or 
power output (1). One identified source of decreased motivation (central drive) is the up-
regulation of the neurotransmitter serotonin during exercise (1). An increase in serotonin, 
and corresponding decrease in dopamine levels, is associated with central fatigue. The 
combination of central and peripheral fatigue has been shown to account for the total loss 
of force during sustained muscle contractions (25). The autonomic nervous system 
(ANS), is composed of both a sympathetic nervous system (SNS) and parasympathetic 
nervous system (PNS) that act as complimentary systems.  Both the SNS and PNS 
influence heart rate by varying impulses in nerve fibers in the sinoatrial node (27). The 
heart is dually innervated by the PNS and ANS, and is up- and down-regulated by the 
two respectively. The central control of heart rate can be demonstrated by the anticipatory 
rise in heart rate seen in athletes prior to race events. Thus without any muscle 
contraction or energy, there is a distinct increase in heart rate. In addition, during exercise 
the CNS stimulation modulates the ANS, and the peripheral sensors then regulate the 
effects according to muscle needs. Previous literature has demonstrated that central 
factors, as opposed to muscular fatigue, are the limiting factors for performance  amongst 
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chronic fatigue patients (28). At lower VO2peak values, but higher ratings of perceived 
exertion (RPE), chronic fatigue patients previously demonstrated significantly lower 
heart rate, indicating a centrally mediated increase in effort perception. This increased 
perception of effort led to subjects’ unwillingness or inability to achieve maximal 
performance. Extending this to normal fatigue processes during intense or long duration 
exercise, central factors may play a limiting role in a person’s ability or willingness to 
achieve high intensity exercise. The central command theory suggests that at the onset of 
exercise centrally controlled signals set the cardiovascular response, while peripheral 
feedback loops are responsible for the fine tuning adjustments as exercise continues. 
Despite the overlap between the two systems, it is clear that both central and peripheral 
factors influence heart rate during exercise (26).  
Nutritional supplementation may be an effective way to delay fatigue onset.  
Recently, beta-alanine (BA), a non-essential amino acid has been shown to effectively 
delay neuromuscular fatigue (10, 11). The direct effect of BA supplementation is to 
increase carnosine levels within the muscle (4, 9). Beta-alanine supplementation has been 
shown to significantly increase intramuscular carnosine levels by as much as 60% (9) and 
also improve exercise performance  by delaying the drop in pH (29).  To date, research 
suggests carnosine’s most effective role is delaying peripheral muscle fatigue by 
maintaining acid-base homeostasis through buffering H
+ 
(9) . With a dissociation content 
(pKa) of 6.83 , carnosine is highly effective at accepting excess H
+
 in the muscle in order 
to maintain intramuscular pH (30). Carnosine is synthesized from L-histidine and BA, but 
due to the high concentration of L-histidine within the plasma, beta-alanine has been 
shown to be the rate-limiting step of muscle carnosine production (9, 31).  
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While beta-alanine’s positive effect on peripheral fatigue via an increase in 
skeletal muscle carnosine are well documented (4, 9, 32), its direct effect on central 
fatigue has not yet been examined. While the highest concentrations of carnosine are in 
skeletal muscle, carnosine has also been  located within the brain (22). High 
concentrations of carnosine are found in the olfactory lobe, which has been shown to 
influence both central and peripheral characteristics (22). One of the side effects 
experienced acutely with BA supplementation, paresthesia (or prickling sensations on the 
skin), is linked to BA activated strychnine-sensitive glycine receptor sites located within 
the spinal cord (33, 34).  It is still undetermined what effect carnosine could have on the 
central nervous system, and, more specifically, delaying central fatigue.  
Various fatigue tests have been utilized to examine the effectiveness of BA 
supplementation. The physical working capacity test has been used to show significant 
increases in physical working capacities following supplementation(10, 15, 16). The 
physical working capacity tests  were originally developed by Moritani et al. 1981 and 
Devries et al. 1982  to measure the point of onset of muscular fatigue (12, 14). The 
researchers utilized electromyographic (EMG) fatigue curves to identify an EMG fatigue 
threshold. Prior to this, however, Monod and Scherrer (1963) found a relationship 
between total work done at varying workloads and the duration of time to fatigue. The 
slope of this relation was termed critical power and represented the power output a 
muscle could maintain without fatigue (13). However, these original measures required 
subjects to perform supramaximal tests, such as a VO2max. Therefore, in 1987, Devries et 
al. completed a follow-up study to submaximally estimate physical working capacity at 
the fatigue threshold (PWCFT) (35).  Theoretically a physical working capacity threshold 
 
 
12 
  
 
represents the highest power output that can be maintained for an extended period of time 
without evidence of fatigue (19). Utilizing submaximal loads and the same principles 
developed by Devries et al. (1987), the physical working capacity at heart rate threshold 
test (PWCHRT) was developed by Wagner and Housh (17) in 1993 in order to identify the 
highest cycle workload an individual can maintain without a significant increase in heart 
rate over an extended period of time (17). Studies utilizing the PWCHRT have found it to 
be highly sensitive to the effects of aerobic training programs (18), as well as an accurate 
estimate of the maximal power output that can be produced without a significant rise in 
heart rate (17). 
The purpose of this study is to determine the effect of four weeks of BA 
supplementation on the physical working capacity at heart rate threshold in men and 
women. By utilizing heart rate as the main measure of fatigue, this study will be 
indirectly examining BA’s effect on both central and peripheral fatigue. Previous 
research on BA has shown that it is effective in delaying fatigue peripherally by 
increasing muscle carnosine, but its effect on central mechanisms is still unknown. The 
physical working capacity tests offer an easy, cost sensitive way to quantify a fatigue 
threshold. The following annotated article review will examine previous research 
describing fatigue, heart rate response to exercise, BA, and physical working capacity 
tests; in order to support the purpose and hypothesis of the present study. 
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Central and Peripheral Fatigue and Heart Rate 
Cooke, Franks, Luciani, and Pate  1988 (5) 
The purpose of this study was to gain a more comprehensive understanding of the 
effects of phosphate and hydrogen ions on parameters of contraction by varying their 
concentrations in rabbit psoas muscles. Dissected psoas fibers from the rabbits were fully 
activated utilizing Ca2
+
 at a constant temperature of 10ºC.  The velocities of induced 
contractions were measured utilizing load clamps. Fiber ATPase was also monitored 
utilizing enzyme coupling of ADP production to reduced NADH, and then measuring the 
depletion of NADH. Results showed that increasing phosphate concentration from 3 to 
20mM at a pH of 7.0 decreases ATPase activity, does not affect maximum contraction 
velocity (Vmax), and causes a 25% decrease isometric tension (P0). Changing the pH from 
7 to 6, while maintaining the 3mM concentration of phosphate, showed a 45% decrease 
inP0. These results are similar to those of other studies which indicated that a decrease in 
muscular pH from 7 to 6 results in a decrease in isometric tension. The main conclusion 
drawn from this study is that most of the fiber contraction inhibition seen in fatiguing 
muscles is explained by product inhibition (H
+ 
and Pi). 
 
Robergs, Ghiasvand, and Parker 2004 (3) 
The focus of this review article was to compile the previous and current literature 
available on metabolic acidosis to form a comprehensive review. Once thought to be a 
major source of metabolic acidosis, lactate is known to play an important role in initial 
buffering of H
+
 accumulation to the lactate dehydrogenase reaction (pyruvate to lactate) 
consuming a proton, thus lactate production acts to alkalinize the cell, and not acidify. 
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The lactate has a further use as it can be transported from the producing cell to be used as 
a substrate for metabolism in other skeletal cells, the liver or kidneys. The real source of 
H
+
 accumulation has been more correctly identified as ATP hydrolysis. A phosphate (Pi) 
is produced and has the ability to buffer the free proton that is released from the water. 
During ATP hydrolysis, the ADP and Pi go on to act as substrates for glycolysis to 
produce more ATP, which leaves the extra proton to accumulate if the other buffering 
systems cannot meet the necessary removal rates. Another source of increased H
+
 could 
be from an accumulation of NADH + H
+
 produced via the glyceraldehydes 3-phosphate 
dehydrogenase reaction step of glycolysis. This could occur when the rate of substrate 
efflux from glycolysis is greater than the mitochondrial activity to accept the products. 
The conclusions of this review were that lactate facilitates proton removal from the 
muscle, lactate production is essential to supporting ATP regeneration from glycolysis, 
and metabolic acidosis results from an increased reliance on non-mitochondrial ATP 
turnover (glycolysis, etc). 
 
Davis, 1995 (1) 
The purpose of this review article was to explore the causes central fatigue, 
specifically the role that brain serotonin (5-HT) plays in leading to central fatigue. This 
article proposes that central fatigue plays a crucial role in limiting overall exercise 
performance. Increased 5-HT is suggested to be the main contributor to central fatigue in 
prolonged exercise due to its known effects on arousal, lethargy and sleepiness.  
Increases in brain 5-HT are due to increases in blood-borne tryptophan (TRP) delivery to 
the brain. Since most TRP is bound to albumin in the blood, it is the free tryptophan (f-
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TRP) that is transported to the brain. The transport mechanism occurs with other amino 
acids, specifically the branched-chain amino acids (BCAAs). Synthesis of brain 5-HT 
increases when the ratio of f-TRP to total plasma BCAAs increases. Animal studies have 
indicated an association between increase levels of brain 5-HT and fatigue during 
continuous prolonged exercise. Another study utilizing rats found that drug-induced 
increases in brain 5-HT lead to faster onset of fatigue whereas drug-induced decreases in 
brain 5-HT lead to a delay in fatigue onset. 
The article also explores the effectiveness of nutritional supplementation to delay 
central fatigue. Studies have indicated that consumption of the large doses of BCAAs 
needed to significantly change the ration of f-TRP to BCAAs would also increase plasma 
ammonia which could lead to toxic effects on the brain and negative changes to 
metabolism. A study utilizing carbohydrate supplementation found that supplementing 
with 6 or 12% carbohydrate-electrolyte drink solutions lead to greatly reduced plasma f-
TRP levels as compared to water supplementation, and that the carbohydrate-electrolyte 
supplement was successful in delaying fatigue. This study contributes to the current body 
of fatigue literature by highlighting the role that central fatigue can play in limiting 
exercise performance, and by indicating the importance of further research on 
mechanisms of central fatigue. 
 
Kent-Braun, 1999 (7) 
The purpose of this study was to estimate the contribution of peripheral and 
central factors to human skeletal muscle fatigue. Nine people (five men, and four women, 
mean age=30) with physical activity levels ranging from sedentary to recreationally 
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active were recruited for this study. Subjects performed a baseline MVC of the 
dorsiflexor muscles, then a sustained isometric MVC for 4 minutes with a titanic 
stimulation at the end of the 4 minutes. An EMG was used to quantify muscle activation 
during maximal voluntary isometric contractions (MVC) of the ankle dorsiflexor 
muscles. Fatigue was quantified by the change in force during the MVC. Measures of 
intramuscular metabolism were also made during the exercise utilizing magnetic 
resonance spectroscopy.   
The results of the study showed a significant difference between the titanic and 
voluntary fatigue (15%), and an overall 78% fall in MVC. Data indicated that 
approximately 20% of the fatigue developed during the sustained MVC was due to 
central fatigue, and the other 80% was due to intramuscular sources such as an increase 
proton concentration. There was a decrease in central activation ratio (CAR), defined as 
the peak MVC/peak total force, which is indicative of a slight central activation failure 
during exercise. 
The study also found significant changes in the intramuscular metabolism during 
exercise. The fall in pH was correlated with the observed fall in force, and the lack of 
peripheral activation failure is indicative of metabolic inhibition leading to fatigue. Other 
studies cited have indicated that there is a linear relationship between [H
+
] and fatigue. 
 
Robinson, Epstein, Beiser, and Braunwaldet, 1966 (27) 
The purpose of this study was to identify the roles of the efferent pathways that 
control heart rate during supine exercise by observing the effects of β-adrenergic 
blockade and parasympathetic blockade on cardiac acceleration. Five people (age 19-28 
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years) were recruited for this study: four normal volunteers and one patient who had 
undergone a successful mitral commissurotomy. All subjects were men who were in good 
physical condition, but were not trained athletes. After familiarization with the 
equipment, the subjects were placed on a tilt table in the supine position and their heart 
rate (HR) was recorded via ECG. The subject was then tilted to 45º and 80º and HR was 
again recorded. The subjects were then moved to a supine bicycle where their HR was 
recorded at rest as well as during the fourth minute of exercise at each series of work 
levels. Oxygen uptake was recorded continuously throughout. The protocol was 
performed 3 more times: one where the cardiac sympathetic nerves were blocked, one 
where the parasympathetic nerves were blocked, and one where both were blocked.  
Sympathetic blockade has been found to lower HR during exercise, suggesting 
sympathetic stimulation is responsible for cardiac acceleration. Results of the study 
indicated that the increase in HR during moderate exercise was due to withdrawal of 
parasympathetic stimulation. At higher workloads, increases in HR were more due to 
sympathetic stimulation.  These results were determined by comparing the double-
blockade response to the single blockade responses of HR.  
 
Beta-Alanine Supplementation 
Derave, Ozdemir, Harris, Pottier, Reyngoudt, Koppo, Wise, and Achten, 2007 (32) 
The purpose of this study was to determine whether 28 days of BA 
supplementation would increase muscle carnosine levels in the calf and improve 
performance in a 400 meter sprint. Fifteen male (age 18.4 ± 1.5 yrs) track-and-field 
athletes, each recording a 400 meter under 53 seconds, were recruited for this study. The 
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study was a placebo-controlled, double-blind study where 7 athletes consumed a placebo 
(maltodextrin) for the duration of the study, and 8 consumed six divided doses of 400mg 
capsules BA CarnoSyn
®
 time release capsules.2.4g/day for the first 4 days, 2.6g/day for 
the next 4 days, and 4.8g/day for the remaining days. A week prior to supplementation, 
pre-testing was performed. A proton magnetic resonance spectroscopy (MRS) was 
utilized to determine initial muscle carnosine concentrations. Isokinetic and isometric 
fatigue tests using a Biodex isokinetic dynamometer was utilized to evaluate the 
contractile performance of the knee extensors. The isokinetic test was performed on the 
right leg that consisted of 5 sets of 30 maximal voluntary isokinetic knee extensions at a 
velocity of 180º/second.  Subjects had a one minute recovery between each set of 30 
repetitions. Peak torque data was measured and used to calculate an average peak torque 
for each set of exercise. The left leg was then use for isometric testing. The knee was 
fixed at 45º, and the maximum voluntary contraction (MVC) torque was recorded. The 
highest of three trials was recorded as their final MVC. Finally, subjects completed a 400 
meter sprint on a separate day, following a self-constructed warm-up routine lasting ~45 
minutes. 
The results of this study showed substantial increases in muscle carnosine (+47% 
in the soleus, +37% in the gastrocnemius). Since the subjects were highly trained athletes, 
these increases were similar to, but slightly lower than other studies that utilized 
untrained subjects. Even subjects with high initial levels of muscle carnsoine saw 
increases in concentration, which suggests a lack of a supplement ceiling. The results of 
this study also showed that in spite of improvements in muscle torque following 
supplementation, there was no significant effect on the 400 meter spring time. Dynamic 
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knee extension torque was significant increased in all 5 bouts following supplementation, 
and increased in the first 2 bouts following a placebo. This suggests that BA 
supplementation can attenuate fatigue in the later stages of exercise. There was no 
significant effect on isometric endurance. 
 
 
Zoeller, Stout, O’Kroy, Torok, and Mielke, 2006 (11) 
The purpose of this study was to determine the effect of four weeks of BA 
supplementation alone or in combination with creatine monohydrate (Cr) on endurance 
performance. Fifty-five men (age 24.5 ± 5.3 years) were recruited for this study. Subjects 
were randomly assigned to one of four supplementation groups: placebo (PL, 34g of 
dextrose; n=13), creatine (Cr; 5.25g of creatine monohydrate plus 34g of dextrose; n=12), 
beta-alanine ( Carnosyn
®
, NAI, San Marcos, CA) (B-Ala; 1.6g beta-alanine plus 34g of 
dextrose; n=14), or beta-alanine plus creatine (Phosphagen Elite
TM
, EAS, Golden, CO) 
(CrBA; 5.25g of creatine monohydrate; 1.6g beta-alanine plus 34g of dextrose; n=16). 
For pre-testing, subjects performed a graded exercise test (GXT) on a cycle ergometer to 
determine VO2peak, ventilatory threshold (VT), and lactate threshold (LT). For the GXT 
protocol, initial power was set to 30 watts, and was increased by 30 watts every 2 minutes 
as the subjects maintained a pedal cadence of 70rpm. The test was stopped when the 
subject could no longer maintain the rpm, or until volitional fatigue. To confirm the test 
was a VO2peak, subjects had to meet the following criteria: a plateau in heart rate (HR) 
values or attainment of HR within 10% of age-predicted HRmax, a plateau in oxygen 
uptake (defined by an increase of no more than150ml/min), and an RER value greater 
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than 1.15. Subjects then completed 28 days of their assigned supplementation protocol 
and finished with post-testing consisting of the same GXT. Results of this study 
demonstrated that the Cr group showed improvements in power at VT and total time to 
exhaustion (TTE), while B-Ala only had improvements in power output at LT. In 
contrast, the combination group, CrBA showed increases in power output at LT, VO2 at 
LT, VO2 at VT, power output at VT, and percent VO2 at VT. This data indicates that 
supplementation with the combination of creatine and beta-alanine may dely the onset of 
fatigue, via LT and VT measures during incremental cycle exercise in men. 
Artioli, Gualano, Smith, Stout, and Lancha 2009 (31) 
The purpose of this review paper was to discuss the current information on 
carnosine and beta-alanine metabolism and to highlight the effects of beta-alanine 
supplementation on exercise performance. For purposes of the present study, the 
important findings will be limited to the effects of beta-alanine supplementation. Beta-
alanine has been shown to effectively increase muscle carnosine after only 28 days of 
supplementation. Harris et al. in 2006 (9)  demonstrated that 800mg is the maximum 
tolerable single dose of beta-alanine, but that this dose could be repeated throughout the 
day if there was a three hour time window between dosings.  Later studies showed that 
using controlled release capsules could be utilized in order to double the dose from 
800mg to 1600mg. A study by Zoeller et al. in 2007 (11) reported that beta-alanine 
improves the anaerobic threshold. Stout et al. in 2007 (10) showed a significant increase 
of 13% on ventilatory threshold in women supplementing with beta-alanine. The 
conclusion from these studies was that the increased buffering capacity created by beta-
alanine supplementation allowed subjects to achieve higher levels of power output with a 
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smaller lactate accumulation. Another study by Stout et al. in 2006 (15) utilized 55 men 
with a mean age of 24.5 to demonstrate beta-alanine’s ability to delay fatigue by 
increasing the physical working capacity at fatigue threshold after 28 days of beta-alanine 
supplementation. Overall, studies utilizing exercise protocols that elicited extreme 
acidosis demonstrated increases in performance linked with beta-alanine 
supplementation. Protocols that elicit less of an acidosis response, (such as those having a 
single bout of exercise lasting less than 60 seconds, or those using small muscle groups) 
resulted in little or no effect from beta-alanine supplementation. Another focus of this 
review was the adverse effects of beta-alanine supplementation. The only known one is 
the symptoms of paresthesia, or tingling sensations, that are triggered by ingesting a high 
single dose of beta-alanine, and tend to disappear within an hour. Controlled time-release 
capsules or smaller dosages can avoid the symptoms altogether. The conclusions of this 
review were that 28 days was a significant amount of time to increase muscle carnosine; 
beta-alanine supplementation can improve fatigue thresholds; and in order to avoid 
paresthesia, controlled time-release capsules should be utilized.  
Stout, Graves, Smith, Hartman, Cramer, Beck, and Harris, 2008(16) 
The purpose of this study was to determine the effects of 90 days of beta-alanine 
supplementation on the onset of neuromuscular fatigue when measured by the physical 
working capacity at fatigue threshold (PWCFT) test in elderly men and women. Twenty-
six untrained men and women were recruited for this study. For pre-testing, subjects 
completed a PWCFT. Subjects were fitted to a cycle ergometer and began pedaling at 50 
rpms with an initial power output determined by the researchers based on participant’s 
self-reported physical fitness. Power output was increased 10-20 watts every two 
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minutes. After each two minutes there was a rest interval long enough to return heart rate 
(HR) to within 10bpm of the arrival HR.  During each workload, EMG samples were 
recorded on the vastus lateralis. PWCFT was determined to be the highest power output 
that resulted in a non-significant slope value for the EMG amplitude verse time 
relationship. Following pre-testing, subjects were randomly assigned to either the beta-
alanine group (BA, 2.4 grams/day of beta-alanine, CarnoSyn
®
, n=12) or the placebo 
group (PL, 2.4 grams/day of microcrystalline cellulose, n=14). All subjects ingested one 
capsule (containing 800mg) three times a day for 90 days. Within three to five days 
following supplementation subjects completed a post-supplementation PWCFT.  Results 
showed a significant increase in PWCFT (+28.6%) in the BA group, but no significant 
change in the PL group. The results of this study indicate that 90 days of beta-alanine 
supplementation in the elderly can significantly increase PWCFT. 
 
Hill, Harris, Kim, Harris, Sale, Boobis, Kim, and Wise, 2007 (4) 
The purposes of this study were to further evaluate the effect of four weeks of 
beta-alanine supplementation on the accumulation of muscle carnosine, to determine if 
changes were fiber specific, and to see if the effects altered results of a high intensity 
cycling capacity test. Twenty-five male subjects who were physically active but not in 
structured training programs were recruited. Following a cycle performance test, subjects 
were split into two groups; one that supplemented with beta-alanine (CarnoSyn
®
) for 
either 4 or 10 weeks (n=13), and one that had a matching placebo (PL).Beta-alanine (BA) 
was divided into 8 daily doses with total dosage per day increasing each week (4.0g-6.4g 
over the study). For determination of muscle carnosine content shifts, a percutaneous 
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muscle biopsy of the vastus lateralis was administered 1-2 days following the cycle test, 
and 1-2 days following the 4 and 10 week tests. For muscle fiber assessment, 20-40 
single muscle fibers were dissected from the 0 and 10 week biopsies of subjects in the 
beta-alanine group. Results showed muscle carnosine concentrations were significantly 
increased at both the 4 (19.9 ± 1.9 mmol/kg dm) and 10 (30.1 ± 2.3 mmol/kg dm) week 
markers for the BA group with no significant changes observed in the control. Muscle 
fiber content changes were not significantly different between type IIa and type I muscle 
fibers. Total muscle carnosine content was greater in type IIa fibers, but the increases 
over the 10 weeks were not significantly different. For the cycling test, total work done 
(TWD) was significantly increased following 4 (+13%) and 10 weeks (16.2%) of BA 
supplementation, with no significant change seen in the control group. The findings of 
this study support BA supplementation as an effective enhancer of muscle carnosine at 
both 4 (+58%) and 10 (+80.1%) weeks. Most importantly, this study showed a 
relationship between greater muscle carnosine content and increased power output via the 
changes seen in TWD in the cycle tests. The authors conclude that this is one of the first 
studies linking improvements in whole body exercise capacity to an increase in 
intracellular H
+ 
buffering content. 
Harris, Tallon, Dunnett, Boobis, Coakley,  Kim, Fallowfield,  Hill, Sale and Wise, 2006 
(9) 
The purpose of this study was to investigate the absorption of BA and the effect 
of supplementation on muscle carnosine synthesis. Six healthy male subjects (age 33.5 ± 
9.9 years) were recruited for this study. All subjects underwent four of the five 
supplementation treatments following an 12 hour overnight fast. Treatment A involved 
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ingesting chicken broth containing 40mg/kg of body weight (bwt) of BA. For treatments 
B, C, D, and E subjects ingested 3ml/kg bwt of a drink containing either 0, 10, 20, or 40 
mg/kg bwt of beta-alanine (CarnoSyn
®
), followed by 5ml/kg bwt of water.  Blood 
samples were taken at 10 minute intervals for the first 90 minutes following 
supplementation and then at 120, 180, 240 and 360 minutes. Complications with subjects 
administered 40mg/kg bwt of beta-alanine arose when they rapidly experienced 
symptoms of flushing (prickly sensations) which began at 20 minutes and lasted an hour. 
As a result of this, two subjects refused the dose and were given 10 and 20 mg/kg bwt 
instead. Symptoms were seen with the 20mg/kg bwt again, but to a much lesser extent. 
There was a significant increase in plasma BA following the chicken broth ingestion, but 
the increase was only half the increase seen in subjects consuming 40mg/kg bwt of beta-
alanine. Important findings in this study indicated that administration of BA above 
10mg/kg bwt was associated with severe flushing symptoms. The chicken broth which 
resulted in similar BA concentrations to those elicited by 20mg/kg bwt supplementation, 
did not lead to any symptoms. 
 
Smith, Stout, Kendall, Fukuda, and Cramer,  2011 (20) 
The purpose of this study was to determine the effects of BA supplementation on 
oxidative stress in women. Twenty-four moderately trained (3-7 days per week of 
aerobic, resistance or recreational activities) women were used in this study. Each subject 
had a total of four laboratory visits. On visit one subjects completed an initial run to 
determine VO2max and peak velocity (PV). No more than 3 days later, subjects came in 
for baseline blood testing and an oxidative stress run. For the oxidative stress test, 
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subjects ran at 70-75% of their PV for 40 minutes. Post run blood samples were collected 
at two and four hours post-exercise. Upon completion of all pre-testing, participants were 
randomly assigned to a placebo (PL) group (800mg/tablet of maltodextrin, 2 tablets 3 
times daily) or a BA group (800 mg/tablet, 2 tablets 3 times daily; CarnoSyn
®
). Subjects 
then supplemented for 28 days, reporting to the lab after two weeks to report intake and 
side effects. Subjects then returned to the lab for post-testing in the form of a VO2 max 
and the 40 minute oxidative stress run. Results of this study showed that, while non-
significant, 28 days of BA supplementation still had a slight influence on aerobic 
performance defined by total time to exhaustion (TTE) and ventilatory threshold (VT). 
Supplementation had no significant effect on the oxidative stress markers- antioxidant 
capacity, superoxide dismutase, glutathione, and 8-Isoprostane. Rating of perceived 
exertion decreased (non-significantly) in the BA group at 30 and 40 minutes of the 
oxidative stress run. Ventilatory threshold also increased non-significantly in the BA 
group suggested an increased buffering capacity and improvement in submaximal 
performance. 
 
Physical Working Capacity Tests 
Stout, Cramer, Mielke, O’Kroy, Torok, and Zoeller, 2006 (15) 
The purpose of this study was to determine the effects of 28 days of beta-alanine 
(BA) and creatine monohydrate (CrM) supplementation on the physical working capacity 
at neuromuscular fatigue threshold (PWCFT). Fifty-one men (age 24.5± 5.3 years), who 
had not ingested creatine or other dietary supplements for the last 12 weeks, were 
recruited for this study. Subjects were fitted with EMG electrodes on their vastus lateralis 
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to use as the measure for neuromuscular fatigue. Subjects were asked to ride an 
electronically braked cycle ergometer at a pedal frequency of 70rpm starting at a 
resistance of 60 watts (W). The power output was increases by 30W every 2 minutes until 
the pedal cadence could not be maintained. At every 2 minute interval six 10-second 
EMG samples were recorded. The PWCFT was calculated later by averaging the highest 
and lowest power output that had non-significant slope values for the EMG amplitude vs. 
time relationship. Following pre-testing, subjects were randomly assigned to one of four 
treatment groups: 1) placebo (PLA; 34g dextrose; n=13), 2) creatine (CrM; 5.25g CrM 
plus 34g dextrose; n=12), 3) b-Ala (1.6g b-Ala plus 34g dextrose; n=12), 4) b-Ala plus 
CrM (CrBA; 5.25 g of CrM plus 1.6g b-Ala plus 34g dextrose; n=14). Subjects took the 
supplements 4 times per day for 6 days, and then twice per day for the last 22. Subjects 
completed the same tests in post-testing as in pre-testing. Results of this study showed 
that b-Ala supplementation could delay the onset of neuromuscular fatigue by 
significantly increasing the PWCFT (+14.5%). The combination of CrBA did not have an 
additive effect to the delay in fatigue, but did significant increase the PWCFT (+11%), 
while Cr alone had no significant effect. These findings suggest that beta-alanine 
supplementation, with or without creatine, may delay the onset of neuromuscular fatigue 
during incremental cycle ergometry. 
 
Wagner and Housh, 1993 (17) 
The purpose of this study was to introduce the physical working capacity at heart 
rate threshold (PWCHRT) test that could be used to estimate the maximal power during 
cycle ergometry that can be maintained for an extended period of time without fatigue. 
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Eight sedentary men (age 22 ± 2 years) were recruited for this study.  The subjects had 
nine laboratory visits, each separated by at least 48 hours. On the first four visits subjects 
completed four different workloads for determination of the PWCHRT, and on the last five 
subjects completed hour long rides in order to validate the PWCHRT. For determination of 
PWCHRT subjects completed four different workloads ranging from 105-200 watts (W). 
Upon reporting to the lab, subjects were fitted to the electronically braked cycle 
ergometer and completed a five minute warm-up at 70rpm with a resistance of 50W. 
Following the warm-up, subjects completed the eight minute work bout at a workload 
chosen so that they could complete the full eight minutes, but would also elicit a positive 
slope in the heart rate verses time relationship. Heart rate was recorded every 15 seconds, 
but only the last five minutes were used to allow for stabilization of the HR and to ensure 
the rise in HR was due to the demands of the workload and not cardiac adjustment. After 
all four workloads were completed, the power outputs were plotted as a function of the 
slope for the HR versus time relationships. The PWCHRT was determined to be the y 
intercept of the plot, or the point of zero slope. For validity of the test, one hour 
continuous work bouts were performed at randomly assigned power outputs equivalent to 
80, 100, 120, 140 and 160% of PWCHRT. Subjects were blinded from the workload until 
completion of all workloads. Warm-up procedures were identical to the PWCHRT trials, 
and following the warm-ups subjects completed an hour long ride at the prescribed 
intensity. Statistical analysis included regression analyses using least squares method and 
t tests were used to determine if there were significant differences between the mean 
slope coefficients for the five one hour rides. Results of the study showed that the HR 
increased significantly (p≤ .05) at all one hour workloads. However, the mean slope 
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coefficients corresponding to workloads equal to or less than the PWCHRT had HR 
increases less than 0.1bpm∙min-1. This minimal rise indicates that the PWCHRT can 
provide an accurate estimate of the power output that can be maintained for an hour 
without significant fatigue. The authors concluded that the PWCHRT would be an 
effective way to assess the effects of interventions designed to increase work capacities. 
 
DeVries, Tichy, Housh, Smyth, Tichy, and Housh, 1987 (35) 
The purpose of this study was to evaluate the physical working capacity at fatigue 
threshold (PWCFT) test on a cycle ergometer with fatigue being determined by EMG 
fatigue curves in the quadriceps muscle. Thirty-two healthy men (age 23.4 ± 3.1 years) 
with fitness levels ranging from sedentary to highly trained athletes were recruited for 
this study. For determination of the PWCFT, subjects completed four pre-determined 
workloads on the cycle ergometer ranging from 420 kp m/min to 1260 kp m/min. Each 
workload lasted two minutes and was followed by a rest period long enough to bring the 
heart rate back to within 10bpm of the initial heart rate. EMG was recorded on the 
quadriceps throughout the two minute work bouts and PWCFT was determined to be the 
lowest workload producing a slope of the EMG amplitude verse time relationship that 
was significantly different than a zero slope. Subjects were also tested for lactate 
threshold (OBLA) via blood draws within 1-2 minutes of each exercise bout, and 
percentage heart rate range at PWCFT. Seventeen subjects were retested for PWCFT a 
week following initial testing to determine reliability. Fifteen subjects were retested for 
OBLA a week following initial testing as well. Results of this study showed that the 
PWCFT was high reproducible with a test re-test correlation of r=0.947. For the unfit 
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quartile of the subjects there was a small non-significant difference between the mean 
power of OBLA and the mean power of PWCFT. However, for the fit quartile, there was a 
significant difference (p≤ .05) between the two mean powers. The authors conclude that 
the results suggest that fit subjects are limited by central factors, whereas in unfit 
subjects, muscular (or peripheral) fatigue factors are the limiter. From this study it can be 
concluded that the PWCFT is an effective and reliable way to evaluate the physical status 
and to monitor training progress in individuals. It is ideally suited for individuals who are 
unable to complete maximal workloads, as the PWCFT utilizes short, submaximal and 
discontinuous workloads. 
 
Weir LL, Weir JP, Housh, and Johnson, 1997(18) 
The purpose of this study was to determine the effect of an eight week aerobic 
training program on the physical working capacity at heart rate threshold (PWCHRT). 
Nineteen college-aged men and women who had not participated in a regular aerobic 
exercise program for at least one year were recruited for this study. For pre- and post-
testing, subjects completed both a VO2max and a PWCHRT on a cycle ergometer. For the 
VO2max subjects completed a five minute warm-up at 30 watts (W). The first stage of the 
test had a resistance of 50W and a required pedal cadence of 70rpm.  The W was 
increased by 30W every two minutes until voluntary exhaustion. The test was considered 
a true VO2max if the subjects met two of the following criteria: a plateau of VO2 with an 
increase in W, maximal heart rate within 15bpm of the age predicted max heart rate, or a 
respiratory exchange ratio (RER) ≥1.1. For determination of PWCHRT, subjects again 
completed a five minute warm-up consisting of a resistance of 50W and a pedal cadence 
 
 
30 
  
 
of 70rpm. Each subject then completed four eight minute workloads (on separate days) 
ranging in resistance from 55-215W. The rate of rise in heart rate as a function of time for 
each workload was determined for each subject. The PWCHRT was calculated by plotting 
the workloads as a function of the slope for the heart rate verse time relationship and 
taking the y-intercept. Following pre-testing, subjects were randomly assigned to either a 
training or control group. The training group completed three exercise sessions a week 
for eight weeks, while the control group had no training sessions and simply maintained 
their normal activities. The training sessions consisted of a five minute warm-up on a 
cycle, followed by 30 minutes of cycling at intensities between 70 and 90% of max heart 
rate at 70rpm. Results of this study showed a significant increase in PWCHRT (30.1 W) 
following training indicating that the PWCHRT is sensitive to an eight week aerobic 
training program. The study also showed only a moderate relationship between VO2max 
and PWCHRT (r
2
= 0.31). This indicates that VO2max and PWCHRT are controlled by 
different mechanisms and cannot be explained by similar variables. There was also a 
decrease in heart rate slope coefficients following training. The authors speculate this 
drop could be due to increased stroke volume, decreased sympathetic drive or an increase 
in parasympathetic activity. Regardless of the mechanism, the decrease itself refutes 
previous research suggesting that heart rate slopes remain stable with training. 
 
Mielke, Housh, Malek, Beck, Hendrix, Schmidt, and Johnson, .2008 (19)  
The purpose of this study was to further validate the PWCHRT and the PWC VO2 
tests by utilizing the results of the tests to find an estimated time to exhaustion (ETTE) 
and then compare the power outputs and estimated time to exhaustion (ETTE) to 
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ventilatory threshold (VT). Ten men and women with a mean age of 23 were recruited for 
the study. Their physical activity status ranged from sedentary (not currently participating 
in aerobic or resistance training) to moderately active (4-5 hours of exercise per week). 
They performed an incremental test to exhaustion on an electronically braked cycle 
ergometer in order to determine VO2peak and VT. VO2peak was identified as the highest 
VO2 value in the last 30 seconds of the test if the subject met two of the termination 
criteria: 1) 90% of age-predicted max HR, 2) respiratory exchange ratio >1.1, 3) a plateau 
of oxygen uptake (defined as <150 ml/min increase in VO2 during the last 30 seconds). 
VT was defined was identified as the VO2 value corresponding to the intersection of two 
regression lines derived from points below and above the breakpoint in the VCO2 vs. 
VO2 relationship. On a separate visit, subjects completed a physical working capacity test 
which included four randomly ordered workloads to exhaustion at different power 
outputs (98-246 watts), to determine the PWCHRT and the PWC VO2. Power curve 
analyses were used to estimate the ETTE at PWCHRT, PWC VO2, and VT. Results 
showed no significant mean differences between the three fatigue thresholds suggesting 
that fatigue thresholds determined by HR and VO2 could be used for estimating VT. The 
power-curve analyses also indicated, contrary to previous studies, that the subjects could 
only maintain the power outputs for the PWCHRT, PWC VO2, and VT for 29 ± 6, 21 ± 3, 
and 27 ± 11 minutes respectively. The authors speculate the differences in this study as 
compared to previous ones could be due to the fatiguing protocol used in this one as well 
as differences in subject training status. The findings of this study for the similar power 
thresholds between PWCHRT, PWC VO2, and VT support the PWCHRT as being a valid 
measure of fatigue threshold. 
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CHAPTER III 
METHODS 
Experimental Design 
All subjects reported to the lab a total of eight or nine times. Prior to enrollment, 
subjects were given an overview of the study and asked to sign an informed consent 
approved by the University’s Institutional Review Board. They were then given a 
physical and a 12-lead resting electrocardiogram (EKG). Depending on the subject’s 
availability the EKG and physical screen were sometimes on separate days (leading to 
some subjects completing the study in 8 visits, and some taking 9). A familiarization trial 
occurred for the peak oxygen consumption test (VO2peak) prior to performing the first 
VO2peaktrial on a cycle ergometer, with 24-48 hours between sessions. The PWCHRT 
testing occurred on visits four and five where subjects performed four randomized 
workloads on two separate days. Following pre-testing, participants were randomly 
assigned to supplementation group A or B (beta-alanine (BA) or placebo (PL)) and 
underwent twenty eight days of supplementation. Following completion of 
supplementation, subjects returned for three post-testing days consisting of a VO2peak, and 
two separate days of PWCHRT.  
 
Subjects 
Thirty eight men and women between the ages of 18 and 31 were recruited for 
this study (Table 1). A total of 30 (16 women and 14 men) subjects completed the study. 
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Eight individuals that were enrolled were not included in the final analysis: one subject 
was not cleared medically, one subject had taken beta-alanine within the last 3 months, 
two suffered outside injuries within the pre-testing phase, and four subjects did not come 
back following enrollment for unknown reasons. Participants were recreationally active 
(accumulating 1-5hrs of exercise per week) and cleared through a physical and resting 
EKG. Participants were excluded if they had taken performance enhancing supplements 
within the previous 3 months, including beta-alanine and creatine. Before pre-testing and 
at the start of post-testing subjects turned in a three day food log to account for any 
dietary changes in consumption of non-essential amino acids throughout the duration of 
the study. During the study the participants were asked to maintain their normal dietary 
and exercise habits. 
 
Peak Oxygen Consumption Test 
Participants performed a total of three VO2peak tests, two pre-supplementation and 
one post-supplementation, on an electronically-braked cycle ergometer (Corival Lode, 
Gronigen, The Netherlands) in order to determine peak oxygen uptake. Upon arrival 
subjects were fitted on a cycle ergometer with the handlebars adjusted to a comfortable 
position and the seat height adjusted so that there was no more than an approximate 15 
degree bend in the knee on full extension. Heart rate (HR) was monitored throughout the 
test using a Polar telemetry system (Polar Electro Inc., Lake Success, NY) Pedal cadence 
was maintained between 60-80 rpms, with an initial power output set at 20 watts (W). 
The workload was increased by 1 W every 3 seconds until the participant could no longer 
maintain the 60-80rpm pedal cadence or volitional fatigue.  Respiratory gases were 
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analyzed throughout the test breath by breath via open-circuit spirometry (Parvo Medics 
TrueMax 2400, Salt Lake City, UT) to determine VO2 peak. This data was averaged over 
15 second increments and the highest 15 second VO2 value elicited during the test was 
considered VO2peak if two of the following criteria are met:  1) Either a plateau in the HR 
or an HR within 10% of the age-predicted max HR, 2) a plateau in VO2 (an increase of 
no more than 150 ml∙min-1), 3) a respiratory exchange ratio (RER) value greater than 
1.15 (ACSM, 1991). The higher of the two pre-supplementation VO2peak tests was 
recorded as the subject’s VO2peak in order to allow for familiarization. There were 24-48 
hours between each testing session.  
 
 Assessment of the physical working capacity at heart rate threshold (PWCHRT) 
For determination of PWCHRT, participants completed four different workloads on 
a Lode electronically-braked cycle ergometer over a period of two days. Workloads were 
randomly assigned each day with two workloads being completed on each of the two 
days. Upon arrival, subjects were fitted with a Polar telemetry system and asked to sit 
passively for five minutes in order to obtain resting HR. Once fitted for seat and 
handlebar height, subjects completed a three minute warm-up at a self-selected pace and 
resistance. Following the warm-up, the subjects completed the eight minute test at one of 
the predetermined workloads (60% of Max Watts, 60%-20W, 60%+20W and 60%+40W) 
.Heart rate was recorded every 30 seconds over the first three minutes, and then every 15 
seconds for the last five minutes of the test (17). Only the last five minutes of HR data 
were used for later computations as the first three minutes were allotted for the 
cardiovascular measures to stabilize. When the eight minute test was completed, the 
subject had a cool down at a self-selected pace. Following the cool down, participants 
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were asked to recover passively for 15 minutes or until they reached 10% of their post 
warm-up HR. The second workload was completed in a similar fashion but without a 
warm-up. Day two of testing occurred 24-48 hours after day one.  
 
Supplementation 
Following pre-testing, participants were randomly assigned to either the placebo 
group (PL: 6.4g/day, 2 tablets 4 times per day maltodextrin) or the beta-alanine group 
(BA: 6.4g/day, 2 tablets 4 times per day; CarnoSyn
®
, Natural Alternative Inc) using a 
double-blind placebo controlled design (Groups A and B). Placebo and beta-alanine 
supplements were identical in appearance and taste. Two capsules were consumed three 
times per day (with at least two hours between each ingestion) for 28 days. Participants 
were required to log daily supplement intake and check in with the study-coordinator 
halfway into supplementation to report consumption and side-effects. Any remaining 
product and dosing logs were returned at post supplementation. 
 
Statistical Analysis 
An analysis of covariance (ANCOVA) was utilized to assess PWCHRT outcomes 
by treatment, corrected for baseline differences in the PWCHRT. Four separate two-way 
mixed factorial ANOVAs [2 × 2; treatment (PL vs. BA) × time (pre vs. post)] were used 
to analyze VO2peak, ventilatory threshold (VT) and total time to exhaustion (TTE). One 
three-way mixed factorial ANOVA [ 4 × 2 × 2; treatment (PL vs. BA) × final HR at each 
workload (60%VO2peak vs. 60% VO2peak-20W vs. 60% VO2peak+20W vs. 60% 
VO2peak+40W) × time (pre vs. post)] was used to evaluate the final HR at each of the four  
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PWC workloads. Ninety-five percent confidence intervals were also used to evaluate 
PWCHRT mean differences, final HR differences, TTE and VT using Excel (Microsoft 
Office Professional Plus 2010). All statistics were run utilizing SPSS Version 20 (IBM; 
Chicago, IL). An alpha level of 0.05 was set a priori. 
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CHAPTER IV 
MANUSCRIPT 
INTRODUCTION 
Beta-alanine (BA) supplementation has been shown to significantly increase 
muscle carnosine levels (9, 32), thereby augmenting muscle buffering capacity (9). 
Previous research suggests that exercise-induced decreases in intramuscular pH, due to an 
accumulation of H
+
, can lead to decreases in power output and a corresponding increase 
in fatigue onset (2).  An endogenous mechanism for buffering H
+ 
accumulation during 
exercise is attributed to muscle carnosine, which assists in maintaining acid-base 
homeostasis by being a H
+
 acceptor (9). Carnosine is synthesized in the body naturally by 
L-histidine and BA (4, 9, 32). Due to naturally high plasma concentration  of L-histidine, 
BA  acts as the rate limiting component of carnosine synthesis (9). Direct carnosine 
supplementation in humans is inefficient due to the activity of carnosinase, which 
immediately breaks down carnosine into its substituents upon ingestion (36, 37). 
Therefore, BA supplementation is supported to be the most effective way to augment 
muscle carnosine concentration.   
Though the highest levels of carnosine lie within skeletal muscle, there are 
sizeable concentrations within brain and cardiac tissues (22). The majority of existing BA 
research has focused on peripheral contributions to fatigue (32, 38). However, there may 
be a need to evaluate the effect of BA on central fatigue mechanisms as well. Previous 
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animal data has suggested augmented carnosine concentrations within the brain can lead 
to significant positive changes in neurological control mechanisms (39, 40). If BA can 
also increase carnosine levels within the brain in humans, it has the potential to assist in 
delaying both peripheral and central aspects of fatigue; however this has yet to be 
evaluated. One indirect measure of central fatigue is heart rate as it is controlled by both 
central and peripheral factors (24). During exercise, an increase in H
+
 and a 
corresponding decrease in pH can stimulate pain receptors(23). These painful afferent 
signals from the muscles inhibit the person’s willingness/motivation to continue 
exercising (23). Heart rate increases correspondingly with the stress placed on the 
cardiovascular system. So as workload increases, so does HR and eventually fatigue 
onset occurs (23). In this case, peripheral factors, combined with central motivation, pain, 
potential sympathetic control, and oxidative stress, may lead to a non-linear increase in 
HR.  If BA can increase carnosine levels within the brain and decrease acidosis, it has the 
potential to assist in delaying fatigue both peripherally and centrally.  
Physical working capacity (PWC) tests have been utilized to quantify fatigue 
onset (12, 14, 17), as well as a tool to examine the influence of potential ergogenic aids, 
such as creatine (11, 15), arginine (41), and BA (10, 15, 16). The PWC test has been 
shown to identify a theoretical point of fatigue onset by regressing a time-distance linear 
relationship (35, 38). Specifically, the physical working capacity at heart rate threshold 
(PWCHRT) utilizes HR as its fatigue quantifier. Wagner and Housh developed the 
PWCHRT in order to estimate a workload that can be sustained on a cycle ergometer for an 
extended period of time without fatigue (a steady-state HR) (17). Previous studies have 
shown it to be sensitive enough to assess aerobic fitness changes (18), but have also 
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found it to over-estimate the maximal power output that can be sustained for an hour ride 
without a significant increase in HR (42). A more recent study found the PWCHRT to be 
both reliable and valid at calculating a PWCHRT that could be maintained over a 45 
minute ride without a significant increase in HR (43). 
Previous PWC tests have been used to quantify the peripheral effects of BA. In 
2006, Stout et al. (10)  demonstrated 28 days of BA supplementation (1.6g/day) 
significantly increased the PWCFT of young males (15) and females (10). In a follow-up 
study, increases in PWCFT resulted from 90 days of 2.4g BA in an elderly population 
(16). No studies have directly examined BA’s effect on central fatigue. However, a recent 
study reported decreases in HR and rating of perceived exertion (RPE) during a moderate 
intensity 40 minute run following 28 days of BA supplementation (4.6g/day) (20). While 
the PWCHRT  cannot differentiate between the potential  effect of BA on central and 
peripheral fatigue, an increased PWCHRT following BA supplementation may indicate an 
influence on both central and peripheral factors of fatigue. Thus this study has the 
potential to determine if future studies, utilizing more sophisticated laboratory 
procedures, should evaluate the central effects of BA.   Therefore the purpose of this 
study is to determine the effects of twenty eight days of beta-alanine supplementation on 
the physical working capacity at heart rate threshold. 
 
METHODS 
Subjects 
Thirty-eight men and women were recruited for the study. Participants were 
excluded from the study if they had consumed beta-alanine or creatine within the 
previous three months, or were not approved following a physical exam. From the initial 
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cohort, 30 subjects completed testing and supplementation (Table 1). Eight individuals 
that were enrolled were not included in the final analysis: one subject was not cleared 
medically, one subject had taken beta-alanine within the last 3 months, two suffered 
outside injuries within the pre-testing phase, and four subjects did not come back 
following enrollment for unknown reasons. 
 
Experimental Design 
 All subjects underwent an initial screening which included a resting EKG 
reading, a medical history and a physical exam. If cleared, subjects underwent a VO2peak 
familiarization trial, and then pre- (baseline) and post-testing for PWCHRT and VO2peak 
using an electronically braked cycle ergometer. Following pre-testing, subjects were 
randomized, in a double-blind manner, to either a placebo (PL; 6.4g/day maltodextrin) or 
beta-alanine (BA; 6.4g/day) group.  Subjects returned to complete post-testing following 
28 days of supplementation. 
 
Determination of VO2peak 
Subjects were fitted with a heart rate monitor and attached to a metabolic cart 
(Parvo Medics TrueMax 2400, Salt Lake City, UT) to measure expired gas samples. 
Subjects maintained a cadence of 60-80 rpm with the workload starting at 20 watts of 
resistance and increasing by one watt every three seconds until the required cadence 
could not be maintained or until volitional fatigue (44). The VO2peak was established as 
the highest VO2 value when at least two of the following criteria were met:  1) Either a 
plateau in the HR or an HR within 10% of the age-predicted max HR; 2) a plateau in VO2 
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(an increase of no more than 150 ml∙min-1); or 3) a respiratory exchange ratio (RER) 
value greater than 1.15 (ACSM, 1991).  Following 24-48 hours of recovery, subjects 
returned for a second VO2peak test following the same methodology, and their second 
VO2peak value was recorded as their peak.  A familiarization VO2peak was included to 
account for any learning effect.  However, the initial two trials were still determined to be 
reliable, ICC: 901; SEM: 3.64 ml·kg·min
-1
, p=0.427. 
 
Determination of PWCHRT 
Subjects completed four different workloads on an electronically-braked cycle 
ergometer (Corival Lode, Gronigen, The Netherlands) over a period of two days. Pre-
determined workloads at percentages of max workload (MW) achieved in the higher of 
the two VO2peak trials (60%MW, 60%-20W, 60%+20W and 60%+40W) were calculated. 
Subjects reported to the lab and were fitted with a heart rate monitor. After sitting 
passively for 5 minutes, their resting heart rate was recorded and they were fitted on a 
cycle. Following a three minute warm-up (self-selected pace and resistance), subjects 
completed an eight minute ride at one of the pre-determined workloads. Workload order 
was randomized for each subject utilizing a random number generator. Heart rate was 
recorded following the warm-up, every 30 seconds for the first three minutes, and then 
every 15 seconds for the last five. Following a self-selected cool down, participants were 
asked to recover passively for 15 minutes or until they reached 10% of their post warm-
up HR. The second workload was completed in a similar fashion but without a warm-up. 
The rate of rise (slope) in heart rate as a function of time for each of the four workloads 
was determined for each subject (Figure 1A). The PWCHRT was then calculated by 
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plotting the workloads as a function of the slope for the heart rate verse time relationship 
(Figure 1B) (17-19, 42). The y-intercept, or point of zero slope was defined as the 
PWCHRT, or the predicted maximum workload that person could maintain. 
 
Supplementation 
Subjects were given a three day food log to complete during pre-testing, prior to 
beginning supplementation in order to account for their current dietary intake. Following 
pre-testing, participants were randomly assigned to either the placebo group (PL: 
6.4g/day, two 800mg tablets four times per day maltodextrin) or the beta-alanine group 
(BA: 6.4g/day, two 800mg tablets four times per day; CarnoSyn
®
, Natural Alternative 
Inc) using a double-blind placebo controlled design. Participants were given supplements 
for 14 days and required to check-in with the primary investigator in order to receive the 
other half of the supplement. Upon completion subjects returned both the dosing logs and 
any leftover pills. During post-testing subjects completed a second three day food log in 
order to ensure no significant dietary changes occurred that could mitigate the potential 
effects of BA. 
 
Statistical Analysis 
An analysis of covariance (ANCOVA) was utilized to assess PWCHRT outcomes 
by treatment, corrected for baseline differences in the PWCHRT. Four separate two-way 
mixed factorial ANOVAs [2 × 2; treatment (PL vs. BA) × time (pre vs. post)] were used 
to analyze VO2peak, ventilatory threshold (VT) and total time to exhaustion (TTE). One 
three-way mixed factorial ANOVA [ 4 × 2 × 2; treatment (PL vs. BA) × final HR at each 
workload (60%VO2peak vs. 60% VO2peak-20W vs. 60% VO2peak+20W vs. 60% 
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VO2peak+40W) × time (pre vs. post)] was used to evaluate the final HR at each of the four 
PWC workloads. Ninety-five percent confidence intervals were also used to evaluate 
PWCHRT mean differences, final HR differences, TTE and VT using Excel (Microsoft 
Office Professional Plus 2010). All statistics were run utilizing SPSS Version 20 (IBM; 
Chicago, IL). An alpha level of 0.05 was set a priori. 
 
RESULTS 
Compliance was reported and reviewed via supplementation logs. All subjects 
met the minimum required dosage (4.8g/day). The average dose per day for all subjects 
was 6.0 ± 0.42 g/day. There were no reported side effects in either group. Data from three 
day dietary records, analyzed using The Food Processor (esha Research, Salem OR, v. 
10.12), demonstrated no significant differences from pre to post-testing for caloric intake 
or macronutrients (Table 2). There were no significant differences between groups 
(p=0.282-0.722).  
 
Physical Working Capacity at Heart Rate Threshold 
ANCOVA results demonstrated a significant time × treatment interaction 
(p=0.000; f=10.732; ηp
2
= 0.479) (Table 3). Mean change scores from pre to post 
supplementation with 95% confidence intervals showed a significant increase in PWCHRT 
(W) for the BA group, and a significant decrease for the PL group (Figure 2). For 
individual change scores, 67% of the BA participants saw a positive change score, 
whereas 60% of the PL participants saw a positive change score (Figure 5).  
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Final HR at Each PWCHRT Workload 
There was no significant three-way interaction (final HR × time × treatment, p= 
0.732; ηp
2
= 0.016). There were no significant two-way interactions (final HR × time; 
p=0.238, ηp
2 = 0.052; final HR× treatment; p=0.963, ηp
2 
= 0.004: time × treatment; 
p=0.574, ηp
2 = 0.012). There was no main effect for time (p=0.065; ηp
2
=0.125) or 
treatment (0=0.071; ηp
2
= 0.120), there was a main effect for final HR between workloads 
(p=0.001 ηp
2
= 0.854). Heart rate was significantly different between all workloads (p= 
0.001). Each progressive workload produced significant increases in final HR (Table 1). 
Mean change scores with 95% confidence intervals showed significant decreases in final 
HR for the first three PWCHRT workloads for both BA and PL groups (Figure 2). The 
highest workload showed a significant increase in final HR for the BA group and a 
significant decrease for the PL group (Figure 2). 
 
Aerobic Capacity 
VO2peak  (L/min) 
There was no significant two-way interaction (time × treatment, p=0.222; 
ηp
2=0.053), and no main effect for time (p= 0.987; ηp
2
= 0.001) or treatment (p= 0.536; 
ηp
2
= 0.014). The mean change score with 95% confidence intervals demonstrated a 
significant decrease in VO2peak in the BA and a significant increase for PL (Figure 3). 
 
VO2peak Time to exhaustion (TTE, sec) 
There was no significant two-way interaction (time × treatment, p= 0.562; ηp
2
= 0.012), 
and no main effect for time (p=0.140; ηp
2=0.076) or treatment (p=0.072; ηp
2
= 0.005). The 
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mean change score with 95% confidence intervals demonstrated a significant increase for 
TTE for both BA and PL groups (Figure 4). 
 
Ventilatory threshold (VT; L/min) 
There was no significant two-way interaction (time × treatment, p=0.134; 
ηp
2=0.078), and no main effect for time (p= 0.422; ηp
2
=0.023) or treatment (p= 0.119; 
ηp
2
=0.084). The mean change score with 95% confidence intervals showed a significant 
increase in VT for PL and a significant decrease for BA (Figure 3). 
 
DISCUSSION 
The primary findings of the present study suggest that 28 days of BA 
supplementation may increase PWCHRT in men and women. Similar results with BA 
supplementation have been reported, demonstrating an increase in physical working 
capacities in women and elderly (10, 15, 16). Most previous literature relied on EMG 
readings as the fatigue quantifier while the present study utilized heart rate as the fatigue 
variable to examine the effect of BA using a submaximal testing approach, and included 
both male and female participants.  
The PWCHRT has been shown to be sensitive to changes in aerobic fitness (18) 
and both reliable and valid as a measure of a HR fatigue threshold (43). The present study 
found significant differences between the BA and PL groups in the ANCOVA testing of 
the raw data measures, aligning well with previous results indicating BA’s positive effect 
on PWC tests (10, 15, 16). This PWCHRT study differs from pervious literature due to the 
use of HR as a fatigue variable and the submaximal nature of the protocol. The ergogenic 
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effects of BA on submaximal workloads have been mixed with most showing a positive 
effect at submaximal workloads,(10, 15, 45), but other results from a study showing no 
effect at submaximal intensities (11). The current study contributes to the current body of 
literature by demonstrating BA’s positive effect on submaximal workloads of short 
duration. Mielke et al. also (19) previously reported similar workloads at VT, PWCVO2 
and PWCHRT; thus, the PWCHRT is applicable as a training threshold that can be utilized 
outside of the laboratory, similar to VT.   
Studies examining the effects of BA supplementation alone on aerobic measures 
have demonstrated no effect on VO2peak (10, 11, 15); mixed results for TTE, with some 
showing an increase in TTE (10, 21), and others indicating no significant changes (11). 
Similar to previous literature, the present study found no significant treatment effect on 
VO2peak. Due to the progressive aerobic nature of VO2peak, it is most dependent on oxygen 
delivery and not likely to be affected by muscle buffering capabilities (46). Since BA’s 
main effect is on muscle buffering, it is therefore not surprising that BA had no effect on 
the outcome. Time to exhaustion in the present study demonstrated significant positive 
change scores for both the BA (4%) and PL (1%) groups (Figure 4), although not 
significantly different from each other. Stout et al, saw an increase (2.5%) in TTE during 
a continuous incremental cycle test following BA supplementation (10). Other studies 
examining TTE however saw no significant improvements following BA 
supplementation (11, 45). Results from TTE demonstrate the need for more research in 
this area due to the conflicting results of both groups increasing TTE, and the conflicting 
literature available. The present study demonstrated no significant change in VT 
(p=0.134). This is in contrast with previous literature suggesting BA may increase VT 
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following 28 days of supplementation (10, 11, 15, 21). Previous research has proven BA 
to be effective at increasing anaerobic thresholds measured by short bouts of intense 
exercise (31, 32).   
The results of this study indicate that twenty eight days of BA supplementation is 
effective at increasing PWCHRT without an exercise intervention. This finding supports 
the concept that BA supplementation is useful for improving fatigue thresholds and 
thereby increasing performance at submaximal workloads. The study, however,  had a 
few limitations. Muscle carnosine was not directly measured, so actual percent increases 
in carnosine content are unknown. Previous studies have shown doses of 4.8-6.4 
grams/day increases carnosine concentration by 60% in 4 weeks (4, 9). It is therefore 
assumed that BA supplementation increased muscle carnosine concentration in the BA 
subjects of this study. Future research should continue to examine the effects of BA on 
other submaximal workloads, as the literature is lacking agreement on BA’s effect on 
aerobic exercise. 
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CHAPTER V 
CONCLUSION 
Four weeks of supplementation with BA demonstrated significant increases in change 
scores for the PWCHRT, TTE and VT. Additionally, final heart rates from each workload were 
significantly different from each other indicating that the HR slopes for each workload were 
significantly different. Since the PWCHRT is calculated utilizing four unique HR slopes from the 
workloads, it is crucial for calculation that the workloads illicit different slopes. The study also is 
the first that used an easily reproducible methodology for workload watt determination for the 
PWCHRT. Future research should continue to examine in more depth BA’s effect on central as 
well as peripheral fatigue, since HR has components of both. Further studies are also needed in 
order to continue to validate the use of PWCHRT as a viable measure of fatigue in a variety of 
populations. Being a submaximal measure of fatigue and minimally invasive as well as cost-
efficient, it lends itself well as a field test for special populations. Finally, studies should continue 
to examine BA’s effect on aerobic measures of fatigue. There is an abundance of research 
focusing BA’s effect on short-term high-intensity exercise, but the present study and others 
indicate BA supplementation may have an effect on moderate duration submaximal exercise. 
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Table 1 
   Age (years) Height (cm) Weight (kg) 
BA (n=15) 20.7 ± 1.1 169.4 ± 7.7 74.5 ± 15.8 
PL (n=15) 21.1 ± 2.8 171.5 ± 7.8 72.3 ± 13.1 
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Table 2   
 
  BA PL 
  Pre Post Pre Post 
Total Avg 2900 ± 1107 2583 ± 1099 2339 ± 920 2305 ± 863 
Fat Avg 995 ±424 872 ± 470 797 ± 416 829 ± 487 
Pro Avg 519 ± 279 447 ± 239 439 ± 161 396 ± 164 
Cho Avg 1182 ± 473 1031 ± 402 1103 ± 548 933 ± 297 
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Table 3  
  
Pre 
PWCHRT 
(W) 
Post 
PWCHRT 
(W) 
∆ Final HR 
60%-20W 
∆ Final 
HR 
60% 
∆ Final HR 
60%+20W 
∆ Final HR 
60%+40W 
BA 
138.6 ± 
63.0 
146.3 ± 
44.9 -2 ± 9 -3 ± 10 -3 ± 6 1 ± 8 
PL 
142.0 ± 
56.7 
134.0 ± 
32.5 -5 ± 6 -2 ± 11 -4 ± 8 -1 ± 7 
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Pre 
PWCHRT 
Post 
PWCHRT Sig. 
Partial Eta 
Squared 
BA 118.298 142.469 
<0.001 0.479 
PL 118.298 129.536 
Table 4  
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